Browsing by Author Gish, R

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 7 of 7 < previous 
TitleAuthor(s)Issue DateViews
 
Decline in hepatitis B surface antigen levels with entecavir treatment in HBeAg-positive nucleoside naive chronic hepatitis B patients-results from phase III study ETV-022
Proceeding/Conference:Gastroenterology
Gish, RChang, TTLai, CLDe Man, RAGadano, AYu, SLlamoso, CTang, H
2012
83
 
HBV infection in immunocompromised patients
Book:Human Virus Guides
Lau, GGish, RLiang, RHS
2005
106
 
Hepatitis B Surface Antigen Loss in Antiviral-treated Patients with HBeAg(+) Chronic Hepatits B (CHB) Infection: Observations from Antiviral-naive Patients Treated with Entecavir (ETV) or lamivudine (LVD)
Proceeding/Conference:Hepatology
Gish, RChang, TTLai, CLde Man, RGadano, APoordad, FZhu, JYang, JBrett-Smith, H
2006
164
 
Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment
Journal:Gut
Yuen, MFWong, DKHSchluep, TLai, CLFerrari, CLocarnini, SLo, RCLGish, RHamilton, JWooddell, CIMak, LYGiven, BD
2021
16
 
Short interfering RNA JNJ-3989 combination therapy in chronic hepatitis B (CHB) shows potent reduction of all viral markers but no correlate was identified for HBsAg reduction and baseline factors
Proceeding/Conference:APASL 2022, Seoul, Korea, 30 Mar - 3 Apr 2022. Hepatology International
Gane, ELocarnini, SLim, THStrasser, SISievert, WCheng, WThompson, AJGiven, BDSchluep, THamilton, JBiermer, MKalmeijer, RBeumont, MLenz, ORidder, FDCloherty, GWong, DKHSchwabe, CJackson, KFerrari, CLai, CLGish, RYuen, RMF
2022
 
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Proceeding/Conference:Hepatology
Ito, KTanaka, YSugiyama, MFujiwara, KSugauchi, FOrito, EAsahina, YTokita, HYuen, RMFLai, CLAcharya, SAGish, RMizokami, M
2005
130
Showing results 2 to 7 of 7 < previous